-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Patients with aneurysmal subarachnoid hemorrhage (SAH-SBI) following a secondary brain injury leading to a ruptured intracranial aneurysm have a poor prognosis
.
Recently, a research article was published in the Journal of Cerebral Blood Flow & Metabolism, the authoritative journal of cerebrovascular and metabolic diseases, which aims to investigate the clinical and pathophysiological relationship between hemoglobin in cerebrospinal fluid (CSF-Hb) and SAH-SBI
.
In a cohort of 47 patients, the researchers collected CSF samples daily for 14 days after the aneurysm ruptured
.
The relationship between cerebrospinal fluid hemoglobin and secondary brain injury after aneurysmal subarachnoid hemorrhage
There is very strong evidence that there is a positive correlation between CSF-Hb and SAH-SBI measured by spectrophotometry
.
The accuracy of CSF-Hb in monitoring SAH-SBI is significantly better than the established method (AUC: 0.
In general, there is a clinical correlation between high CSF-Hb levels and SAH-SBI.
There is a clinical correlation between high CSF-Hb levels and SAH-SBI.
Original source:
Kevin Akeret.
Cerebrospinal fluid hemoglobin drives subarachnoid hemorrhage-related secondary brain injury in this message